CDTX stock · FAST stock

CDTX vs FAST

Cidara Therapeutics Inc (CDTX) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.

Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.

Fastenal Company (FAST) is a industrial distribution company listed on US.

Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.

Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.

CDTX currently screens at market cap $6.96B. FAST currently screens at market cap $49.48B and trailing P/E 43.1.

Not investment advice. Open the CDTX and FAST stock pages for the full models.

Not investment advice.

Popular Stock Comparisons